Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
Conditions: Neuroblastoma; Sarcoma; Rhabdomyosarcoma-Embryonal; Rhabdomyosarcoma- Alveolar; Neuroectodermal Tumors, Primitive, PeripheralInterventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes; Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine; Drug: rhIL-7; Biological: Tumor Lysate/KLH Pulsed Dendritic Cell VaccineSponsor: National Cancer Institute (NCI)Suspended - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Cancer & Oncology | Embryonal Carcinoma | Ewing's Sarcoma | Neuroblastoma | Neurology | Research | Rhabdomyosarcoma | Sarcomas | Vaccines